nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR3A—enteric nervous system—Crohn's disease	0.0788	0.195	CbGeAlD
Amoxapine—HTR3A—myenteric nerve plexus—Crohn's disease	0.0597	0.148	CbGeAlD
Amoxapine—HTR7—enteric nervous system—Crohn's disease	0.051	0.126	CbGeAlD
Amoxapine—HTR7—myenteric nerve plexus—Crohn's disease	0.0386	0.0955	CbGeAlD
Amoxapine—ORM1—bile—Crohn's disease	0.037	0.0916	CbGeAlD
Amoxapine—HTR2A—enteric nervous system—Crohn's disease	0.0318	0.0786	CbGeAlD
Amoxapine—HTR2A—myenteric nerve plexus—Crohn's disease	0.0241	0.0596	CbGeAlD
Amoxapine—Drug fever—Mercaptopurine—Crohn's disease	0.0205	0.0925	CcSEcCtD
Amoxapine—Drug fever—Mesalazine—Crohn's disease	0.0111	0.0502	CcSEcCtD
Amoxapine—ORM1—gall bladder—Crohn's disease	0.0103	0.0254	CbGeAlD
Amoxapine—Tongue discolouration—Mesalazine—Crohn's disease	0.00769	0.0347	CcSEcCtD
Amoxapine—HTR7—mouth—Crohn's disease	0.00661	0.0163	CbGeAlD
Amoxapine—HTR3A—digestive system—Crohn's disease	0.00452	0.0112	CbGeAlD
Amoxapine—HTR2B—smooth muscle tissue—Crohn's disease	0.00433	0.0107	CbGeAlD
Amoxapine—HTR2B—skin of body—Crohn's disease	0.00427	0.0106	CbGeAlD
Amoxapine—Pancreatitis—Mercaptopurine—Crohn's disease	0.00421	0.019	CcSEcCtD
Amoxapine—Vasculitis—Azathioprine—Crohn's disease	0.00418	0.0189	CcSEcCtD
Amoxapine—HTR7—epithelium—Crohn's disease	0.00385	0.00951	CbGeAlD
Amoxapine—Stomatitis—Mercaptopurine—Crohn's disease	0.00373	0.0168	CcSEcCtD
Amoxapine—ADRA1A—epithelium—Crohn's disease	0.00371	0.00917	CbGeAlD
Amoxapine—HTR7—smooth muscle tissue—Crohn's disease	0.00371	0.00916	CbGeAlD
Amoxapine—Menstruation irregular—Prednisone—Crohn's disease	0.00355	0.016	CcSEcCtD
Amoxapine—SLC6A4—digestive system—Crohn's disease	0.00345	0.00853	CbGeAlD
Amoxapine—HTR2B—digestive system—Crohn's disease	0.00342	0.00845	CbGeAlD
Amoxapine—Alopecia—Mercaptopurine—Crohn's disease	0.00304	0.0137	CcSEcCtD
Amoxapine—Disorientation—Mesalazine—Crohn's disease	0.00302	0.0136	CcSEcCtD
Amoxapine—HTR7—digestive system—Crohn's disease	0.00293	0.00723	CbGeAlD
Amoxapine—Libido decreased—Mesalazine—Crohn's disease	0.00291	0.0131	CcSEcCtD
Amoxapine—Increased appetite—Mesalazine—Crohn's disease	0.00287	0.0129	CcSEcCtD
Amoxapine—HRH1—epithelium—Crohn's disease	0.00287	0.0071	CbGeAlD
Amoxapine—ADRA1A—lymphoid tissue—Crohn's disease	0.00286	0.00706	CbGeAlD
Amoxapine—Atrial fibrillation—Mesalazine—Crohn's disease	0.00285	0.0128	CcSEcCtD
Amoxapine—Delusion—Prednisone—Crohn's disease	0.00278	0.0125	CcSEcCtD
Amoxapine—HRH1—smooth muscle tissue—Crohn's disease	0.00277	0.00684	CbGeAlD
Amoxapine—Leukopenia—Mercaptopurine—Crohn's disease	0.00268	0.0121	CcSEcCtD
Amoxapine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00268	0.0121	CcSEcCtD
Amoxapine—Pancreatitis—Azathioprine—Crohn's disease	0.00251	0.0113	CcSEcCtD
Amoxapine—HRH1—mammalian vulva—Crohn's disease	0.00249	0.00616	CbGeAlD
Amoxapine—ADRA2A—mammalian vulva—Crohn's disease	0.00245	0.00605	CbGeAlD
Amoxapine—Oedema—Mercaptopurine—Crohn's disease	0.00244	0.011	CcSEcCtD
Amoxapine—HTR2A—epithelium—Crohn's disease	0.0024	0.00593	CbGeAlD
Amoxapine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00239	0.0108	CcSEcCtD
Amoxapine—Petechiae—Prednisone—Crohn's disease	0.00239	0.0108	CcSEcCtD
Amoxapine—Anorexia—Mercaptopurine—Crohn's disease	0.00233	0.0105	CcSEcCtD
Amoxapine—ORM1—lymph node—Crohn's disease	0.00231	0.00571	CbGeAlD
Amoxapine—HTR2A—smooth muscle tissue—Crohn's disease	0.00231	0.00571	CbGeAlD
Amoxapine—Eosinophilia—Mesalazine—Crohn's disease	0.00231	0.0104	CcSEcCtD
Amoxapine—Pancreatitis—Mesalazine—Crohn's disease	0.00229	0.0103	CcSEcCtD
Amoxapine—HRH1—digestive system—Crohn's disease	0.00218	0.0054	CbGeAlD
Amoxapine—Pollakiuria—Mesalazine—Crohn's disease	0.00215	0.00971	CcSEcCtD
Amoxapine—Agranulocytosis—Azathioprine—Crohn's disease	0.00213	0.00961	CcSEcCtD
Amoxapine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00212	0.00958	CcSEcCtD
Amoxapine—Weight increased—Mesalazine—Crohn's disease	0.00212	0.00957	CcSEcCtD
Amoxapine—Stomatitis—Mesalazine—Crohn's disease	0.00203	0.00914	CcSEcCtD
Amoxapine—Jaundice—Mesalazine—Crohn's disease	0.00203	0.00914	CcSEcCtD
Amoxapine—Vasculitis—Prednisone—Crohn's disease	0.00201	0.00909	CcSEcCtD
Amoxapine—HTR2B—lymph node—Crohn's disease	0.00195	0.00483	CbGeAlD
Amoxapine—Agranulocytosis—Mesalazine—Crohn's disease	0.00194	0.00875	CcSEcCtD
Amoxapine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00193	0.00871	CcSEcCtD
Amoxapine—Hepatitis—Mesalazine—Crohn's disease	0.00187	0.00842	CcSEcCtD
Amoxapine—HTR2A—digestive system—Crohn's disease	0.00182	0.00451	CbGeAlD
Amoxapine—Alopecia—Azathioprine—Crohn's disease	0.00181	0.00817	CcSEcCtD
Amoxapine—Tinnitus—Mesalazine—Crohn's disease	0.00174	0.00785	CcSEcCtD
Amoxapine—SLC6A2—lymph node—Crohn's disease	0.00173	0.00429	CbGeAlD
Amoxapine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00167	0.00754	CcSEcCtD
Amoxapine—CYP2D6—digestive system—Crohn's disease	0.00166	0.00411	CbGeAlD
Amoxapine—Alopecia—Mesalazine—Crohn's disease	0.00165	0.00744	CcSEcCtD
Amoxapine—Flatulence—Mesalazine—Crohn's disease	0.0016	0.00722	CcSEcCtD
Amoxapine—Leukopenia—Azathioprine—Crohn's disease	0.0016	0.0072	CcSEcCtD
Amoxapine—Vascular purpura—Prednisone—Crohn's disease	0.0016	0.0072	CcSEcCtD
Amoxapine—Tension—Mesalazine—Crohn's disease	0.00159	0.00719	CcSEcCtD
Amoxapine—Dysgeusia—Mesalazine—Crohn's disease	0.00159	0.00718	CcSEcCtD
Amoxapine—Nervousness—Mesalazine—Crohn's disease	0.00158	0.00712	CcSEcCtD
Amoxapine—Vomiting—Mercaptopurine—Crohn's disease	0.00155	0.00701	CcSEcCtD
Amoxapine—Rash—Mercaptopurine—Crohn's disease	0.00154	0.00695	CcSEcCtD
Amoxapine—Dermatitis—Mercaptopurine—Crohn's disease	0.00154	0.00694	CcSEcCtD
Amoxapine—Vision blurred—Mesalazine—Crohn's disease	0.00153	0.00691	CcSEcCtD
Amoxapine—Tremor—Mesalazine—Crohn's disease	0.00152	0.00686	CcSEcCtD
Amoxapine—Increased appetite—Prednisone—Crohn's disease	0.00152	0.00685	CcSEcCtD
Amoxapine—Purpura—Prednisone—Crohn's disease	0.00148	0.00668	CcSEcCtD
Amoxapine—Syncope—Mesalazine—Crohn's disease	0.00146	0.00657	CcSEcCtD
Amoxapine—Leukopenia—Mesalazine—Crohn's disease	0.00145	0.00656	CcSEcCtD
Amoxapine—Nausea—Mercaptopurine—Crohn's disease	0.00145	0.00654	CcSEcCtD
Amoxapine—Palpitations—Mesalazine—Crohn's disease	0.00144	0.00647	CcSEcCtD
Amoxapine—Loss of consciousness—Mesalazine—Crohn's disease	0.00143	0.00644	CcSEcCtD
Amoxapine—Thrombocytopenia—Azathioprine—Crohn's disease	0.00143	0.00643	CcSEcCtD
Amoxapine—Hypertension—Mesalazine—Crohn's disease	0.0014	0.00633	CcSEcCtD
Amoxapine—Hypotension—Azathioprine—Crohn's disease	0.00136	0.00613	CcSEcCtD
Amoxapine—Dry mouth—Mesalazine—Crohn's disease	0.00135	0.0061	CcSEcCtD
Amoxapine—Confusional state—Mesalazine—Crohn's disease	0.00134	0.00603	CcSEcCtD
Amoxapine—Oedema—Mesalazine—Crohn's disease	0.00133	0.00598	CcSEcCtD
Amoxapine—Shock—Mesalazine—Crohn's disease	0.0013	0.00588	CcSEcCtD
Amoxapine—Thrombocytopenia—Mesalazine—Crohn's disease	0.0013	0.00585	CcSEcCtD
Amoxapine—Tachycardia—Mesalazine—Crohn's disease	0.00129	0.00584	CcSEcCtD
Amoxapine—Anorexia—Mesalazine—Crohn's disease	0.00126	0.0057	CcSEcCtD
Amoxapine—HRH1—lymph node—Crohn's disease	0.00125	0.00309	CbGeAlD
Amoxapine—Hypotension—Mesalazine—Crohn's disease	0.00124	0.00559	CcSEcCtD
Amoxapine—ADRA2A—lymph node—Crohn's disease	0.00123	0.00303	CbGeAlD
Amoxapine—Pancreatitis—Prednisone—Crohn's disease	0.00121	0.00545	CcSEcCtD
Amoxapine—Feeling abnormal—Azathioprine—Crohn's disease	0.0012	0.00541	CcSEcCtD
Amoxapine—Insomnia—Mesalazine—Crohn's disease	0.0012	0.00541	CcSEcCtD
Amoxapine—Paraesthesia—Mesalazine—Crohn's disease	0.00119	0.00537	CcSEcCtD
Amoxapine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00119	0.00537	CcSEcCtD
Amoxapine—Somnolence—Mesalazine—Crohn's disease	0.00118	0.00532	CcSEcCtD
Amoxapine—Dyspepsia—Mesalazine—Crohn's disease	0.00117	0.00526	CcSEcCtD
Amoxapine—Decreased appetite—Mesalazine—Crohn's disease	0.00115	0.0052	CcSEcCtD
Amoxapine—Abdominal pain—Azathioprine—Crohn's disease	0.00115	0.00519	CcSEcCtD
Amoxapine—Body temperature increased—Azathioprine—Crohn's disease	0.00115	0.00519	CcSEcCtD
Amoxapine—Fatigue—Mesalazine—Crohn's disease	0.00114	0.00516	CcSEcCtD
Amoxapine—Erectile dysfunction—Prednisone—Crohn's disease	0.00114	0.00512	CcSEcCtD
Amoxapine—Constipation—Mesalazine—Crohn's disease	0.00113	0.00511	CcSEcCtD
Amoxapine—Weight increased—Prednisone—Crohn's disease	0.00112	0.00506	CcSEcCtD
Amoxapine—Feeling abnormal—Mesalazine—Crohn's disease	0.00109	0.00493	CcSEcCtD
Amoxapine—Acute coronary syndrome—Prednisone—Crohn's disease	0.00108	0.00489	CcSEcCtD
Amoxapine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00108	0.00489	CcSEcCtD
Amoxapine—Myocardial infarction—Prednisone—Crohn's disease	0.00108	0.00486	CcSEcCtD
Amoxapine—Urticaria—Mesalazine—Crohn's disease	0.00105	0.00475	CcSEcCtD
Amoxapine—Abdominal pain—Mesalazine—Crohn's disease	0.00105	0.00473	CcSEcCtD
Amoxapine—Body temperature increased—Mesalazine—Crohn's disease	0.00105	0.00473	CcSEcCtD
Amoxapine—Diarrhoea—Azathioprine—Crohn's disease	0.000996	0.00449	CcSEcCtD
Amoxapine—Hallucination—Prednisone—Crohn's disease	0.000983	0.00443	CcSEcCtD
Amoxapine—Dizziness—Azathioprine—Crohn's disease	0.000963	0.00434	CcSEcCtD
Amoxapine—Asthenia—Mesalazine—Crohn's disease	0.000951	0.00429	CcSEcCtD
Amoxapine—Pruritus—Mesalazine—Crohn's disease	0.000938	0.00423	CcSEcCtD
Amoxapine—Vomiting—Azathioprine—Crohn's disease	0.000926	0.00417	CcSEcCtD
Amoxapine—Rash—Azathioprine—Crohn's disease	0.000918	0.00414	CcSEcCtD
Amoxapine—Dermatitis—Azathioprine—Crohn's disease	0.000917	0.00414	CcSEcCtD
Amoxapine—Headache—Azathioprine—Crohn's disease	0.000912	0.00411	CcSEcCtD
Amoxapine—Diarrhoea—Mesalazine—Crohn's disease	0.000907	0.00409	CcSEcCtD
Amoxapine—Dizziness—Mesalazine—Crohn's disease	0.000877	0.00395	CcSEcCtD
Amoxapine—Alopecia—Prednisone—Crohn's disease	0.000873	0.00394	CcSEcCtD
Amoxapine—Nausea—Azathioprine—Crohn's disease	0.000865	0.0039	CcSEcCtD
Amoxapine—Vomiting—Mesalazine—Crohn's disease	0.000843	0.0038	CcSEcCtD
Amoxapine—Rash—Mesalazine—Crohn's disease	0.000836	0.00377	CcSEcCtD
Amoxapine—Dermatitis—Mesalazine—Crohn's disease	0.000835	0.00377	CcSEcCtD
Amoxapine—Headache—Mesalazine—Crohn's disease	0.000831	0.00375	CcSEcCtD
Amoxapine—Vision blurred—Prednisone—Crohn's disease	0.00081	0.00365	CcSEcCtD
Amoxapine—Agitation—Prednisone—Crohn's disease	0.00079	0.00356	CcSEcCtD
Amoxapine—Nausea—Mesalazine—Crohn's disease	0.000788	0.00355	CcSEcCtD
Amoxapine—Syncope—Prednisone—Crohn's disease	0.000771	0.00348	CcSEcCtD
Amoxapine—Loss of consciousness—Prednisone—Crohn's disease	0.000756	0.00341	CcSEcCtD
Amoxapine—Convulsion—Prednisone—Crohn's disease	0.000745	0.00336	CcSEcCtD
Amoxapine—Hypertension—Prednisone—Crohn's disease	0.000742	0.00335	CcSEcCtD
Amoxapine—Oedema—Prednisone—Crohn's disease	0.000702	0.00316	CcSEcCtD
Amoxapine—Shock—Prednisone—Crohn's disease	0.00069	0.00311	CcSEcCtD
Amoxapine—Tachycardia—Prednisone—Crohn's disease	0.000685	0.00309	CcSEcCtD
Amoxapine—Anorexia—Prednisone—Crohn's disease	0.000669	0.00302	CcSEcCtD
Amoxapine—Insomnia—Prednisone—Crohn's disease	0.000635	0.00286	CcSEcCtD
Amoxapine—Paraesthesia—Prednisone—Crohn's disease	0.00063	0.00284	CcSEcCtD
Amoxapine—Dyspepsia—Prednisone—Crohn's disease	0.000618	0.00278	CcSEcCtD
Amoxapine—Decreased appetite—Prednisone—Crohn's disease	0.00061	0.00275	CcSEcCtD
Amoxapine—Fatigue—Prednisone—Crohn's disease	0.000605	0.00273	CcSEcCtD
Amoxapine—Constipation—Prednisone—Crohn's disease	0.0006	0.00271	CcSEcCtD
Amoxapine—Feeling abnormal—Prednisone—Crohn's disease	0.000578	0.00261	CcSEcCtD
Amoxapine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000574	0.00259	CcSEcCtD
Amoxapine—Urticaria—Prednisone—Crohn's disease	0.000557	0.00251	CcSEcCtD
Amoxapine—Body temperature increased—Prednisone—Crohn's disease	0.000555	0.0025	CcSEcCtD
Amoxapine—Abdominal pain—Prednisone—Crohn's disease	0.000555	0.0025	CcSEcCtD
Amoxapine—Asthenia—Prednisone—Crohn's disease	0.000503	0.00227	CcSEcCtD
Amoxapine—Pruritus—Prednisone—Crohn's disease	0.000496	0.00224	CcSEcCtD
Amoxapine—Diarrhoea—Prednisone—Crohn's disease	0.00048	0.00216	CcSEcCtD
Amoxapine—Dizziness—Prednisone—Crohn's disease	0.000464	0.00209	CcSEcCtD
Amoxapine—Vomiting—Prednisone—Crohn's disease	0.000446	0.00201	CcSEcCtD
Amoxapine—Rash—Prednisone—Crohn's disease	0.000442	0.00199	CcSEcCtD
Amoxapine—Dermatitis—Prednisone—Crohn's disease	0.000442	0.00199	CcSEcCtD
Amoxapine—Headache—Prednisone—Crohn's disease	0.00044	0.00198	CcSEcCtD
Amoxapine—Nausea—Prednisone—Crohn's disease	0.000417	0.00188	CcSEcCtD
Amoxapine—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	6.6e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	6.58e-05	0.000176	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RBX1—Crohn's disease	6.56e-05	0.000175	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	6.55e-05	0.000175	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RBX1—Crohn's disease	6.54e-05	0.000175	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RBX1—Crohn's disease	6.52e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—CXCL8—Crohn's disease	6.51e-05	0.000174	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	6.49e-05	0.000174	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	6.48e-05	0.000173	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—JAK2—Crohn's disease	6.48e-05	0.000173	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	6.46e-05	0.000173	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	6.45e-05	0.000173	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	6.45e-05	0.000172	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	6.43e-05	0.000172	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—SMAD3—Crohn's disease	6.43e-05	0.000172	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—SMAD3—Crohn's disease	6.43e-05	0.000172	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—JAK2—Crohn's disease	6.42e-05	0.000172	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	6.42e-05	0.000172	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	6.42e-05	0.000172	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SOCS1—Crohn's disease	6.41e-05	0.000172	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	6.41e-05	0.000172	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	6.38e-05	0.000171	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PTGER4—Crohn's disease	6.37e-05	0.00017	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GPX4—Crohn's disease	6.35e-05	0.00017	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	6.35e-05	0.00017	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—JAK2—Crohn's disease	6.34e-05	0.00017	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SOCS1—Crohn's disease	6.33e-05	0.000169	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	6.31e-05	0.000169	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL3—Crohn's disease	6.29e-05	0.000168	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL3—Crohn's disease	6.26e-05	0.000167	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	6.25e-05	0.000167	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	6.25e-05	0.000167	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	6.22e-05	0.000166	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	6.19e-05	0.000165	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—CXCL8—Crohn's disease	6.18e-05	0.000165	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—CXCL8—Crohn's disease	6.18e-05	0.000165	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—SMAD3—Crohn's disease	6.15e-05	0.000165	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CXCL8—Crohn's disease	6.14e-05	0.000164	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GCKR—Crohn's disease	6.13e-05	0.000164	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—TYK2—Crohn's disease	6.11e-05	0.000164	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	6.09e-05	0.000163	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	6.06e-05	0.000162	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—TYK2—Crohn's disease	6.03e-05	0.000161	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	6.01e-05	0.000161	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	5.97e-05	0.00016	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL2RA—Crohn's disease	5.96e-05	0.000159	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL2RA—Crohn's disease	5.95e-05	0.000159	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	5.91e-05	0.000158	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	5.87e-05	0.000157	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	5.87e-05	0.000157	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	5.86e-05	0.000157	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	5.84e-05	0.000156	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—IL6—Crohn's disease	5.84e-05	0.000156	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—JAK2—Crohn's disease	5.83e-05	0.000156	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	5.81e-05	0.000155	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	5.79e-05	0.000155	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	5.78e-05	0.000155	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—JAK2—Crohn's disease	5.76e-05	0.000154	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	5.75e-05	0.000154	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	5.74e-05	0.000153	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	5.72e-05	0.000153	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL2RA—Crohn's disease	5.69e-05	0.000152	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	5.67e-05	0.000152	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	5.65e-05	0.000151	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	5.63e-05	0.000151	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	5.58e-05	0.000149	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RIPK2—Crohn's disease	5.56e-05	0.000149	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	5.55e-05	0.000148	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SMAD3—Crohn's disease	5.54e-05	0.000148	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL3—Crohn's disease	5.53e-05	0.000148	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	5.52e-05	0.000148	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	5.51e-05	0.000148	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	5.5e-05	0.000147	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	5.49e-05	0.000147	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SMAD3—Crohn's disease	5.46e-05	0.000146	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	5.46e-05	0.000146	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL3—Crohn's disease	5.44e-05	0.000145	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	5.44e-05	0.000145	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL3—Crohn's disease	5.43e-05	0.000145	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL3—Crohn's disease	5.41e-05	0.000145	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	5.34e-05	0.000143	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	5.32e-05	0.000142	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	5.32e-05	0.000142	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	5.26e-05	0.000141	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	5.26e-05	0.000141	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	5.25e-05	0.000141	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	5.25e-05	0.00014	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	5.23e-05	0.00014	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	5.23e-05	0.00014	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	5.23e-05	0.00014	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	5.15e-05	0.000138	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL2RA—Crohn's disease	5.13e-05	0.000137	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	5.07e-05	0.000136	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL2RA—Crohn's disease	5.06e-05	0.000135	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	5.04e-05	0.000135	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	5.02e-05	0.000134	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	5.02e-05	0.000134	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	4.99e-05	0.000133	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	4.95e-05	0.000132	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—STAT3—Crohn's disease	4.94e-05	0.000132	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	4.85e-05	0.00013	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	4.84e-05	0.00013	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	4.78e-05	0.000128	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	4.77e-05	0.000128	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	4.76e-05	0.000127	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	4.76e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	4.76e-05	0.000127	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	4.75e-05	0.000127	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	4.75e-05	0.000127	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	4.74e-05	0.000127	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	4.74e-05	0.000127	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	4.67e-05	0.000125	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	4.66e-05	0.000125	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	4.62e-05	0.000123	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	4.58e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	4.55e-05	0.000122	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	4.54e-05	0.000122	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	4.53e-05	0.000121	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	4.52e-05	0.000121	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	4.45e-05	0.000119	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	4.43e-05	0.000118	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	4.41e-05	0.000118	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	4.4e-05	0.000118	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	4.39e-05	0.000117	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.36e-05	0.000116	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	4.35e-05	0.000116	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	4.34e-05	0.000116	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	4.33e-05	0.000116	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	4.33e-05	0.000116	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	4.33e-05	0.000116	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	4.32e-05	0.000116	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	4.31e-05	0.000115	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	4.26e-05	0.000114	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	4.24e-05	0.000113	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TYK2—Crohn's disease	4.2e-05	0.000112	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TYK2—Crohn's disease	4.19e-05	0.000112	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	4.18e-05	0.000112	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	4.13e-05	0.000111	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	4.11e-05	0.00011	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	4.1e-05	0.00011	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	4.09e-05	0.000109	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TYK2—Crohn's disease	4.08e-05	0.000109	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	4.03e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	4.02e-05	0.000108	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TYK2—Crohn's disease	4.01e-05	0.000107	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—JAK2—Crohn's disease	4e-05	0.000107	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—JAK2—Crohn's disease	4e-05	0.000107	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.96e-05	0.000106	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	3.96e-05	0.000106	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	3.95e-05	0.000106	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	3.94e-05	0.000105	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	3.93e-05	0.000105	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—JAK2—Crohn's disease	3.89e-05	0.000104	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	3.87e-05	0.000104	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	3.87e-05	0.000104	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TYK2—Crohn's disease	3.83e-05	0.000102	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—JAK2—Crohn's disease	3.83e-05	0.000102	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	3.81e-05	0.000102	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	3.8e-05	0.000102	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	3.79e-05	0.000101	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	3.74e-05	0.0001	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	3.73e-05	9.98e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—JAK2—Crohn's disease	3.65e-05	9.77e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CXCL8—Crohn's disease	3.65e-05	9.77e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CXCL8—Crohn's disease	3.65e-05	9.76e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TYK2—Crohn's disease	3.61e-05	9.66e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	3.6e-05	9.62e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TYK2—Crohn's disease	3.56e-05	9.53e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	3.55e-05	9.5e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CXCL8—Crohn's disease	3.49e-05	9.34e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—IL6—Crohn's disease	3.47e-05	9.29e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—IL6—Crohn's disease	3.47e-05	9.28e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	3.47e-05	9.27e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—IL6—Crohn's disease	3.45e-05	9.23e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—JAK2—Crohn's disease	3.45e-05	9.22e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—JAK2—Crohn's disease	3.4e-05	9.09e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—IL6—Crohn's disease	3.38e-05	9.03e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	3.33e-05	8.92e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—IL6—Crohn's disease	3.32e-05	8.89e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—Crohn's disease	3.17e-05	8.48e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	3.15e-05	8.41e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TYK2—Crohn's disease	3.11e-05	8.31e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL8—Crohn's disease	3.1e-05	8.3e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	3.09e-05	8.27e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ALB—Crohn's disease	3e-05	8.01e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—Crohn's disease	2.99e-05	8e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—JAK2—Crohn's disease	2.96e-05	7.93e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—Crohn's disease	2.95e-05	7.89e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	2.95e-05	7.89e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—STAT3—Crohn's disease	2.94e-05	7.86e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—STAT3—Crohn's disease	2.93e-05	7.85e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—STAT3—Crohn's disease	2.86e-05	7.64e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—STAT3—Crohn's disease	2.81e-05	7.52e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TYK2—Crohn's disease	2.73e-05	7.29e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	2.7e-05	7.23e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	2.69e-05	7.2e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	2.68e-05	7.18e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—STAT3—Crohn's disease	2.68e-05	7.17e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TYK2—Crohn's disease	2.68e-05	7.16e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	2.67e-05	7.14e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	2.63e-05	7.03e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—Crohn's disease	2.62e-05	7.01e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—JAK2—Crohn's disease	2.6e-05	6.96e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—Crohn's disease	2.57e-05	6.88e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.56e-05	6.85e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	2.56e-05	6.84e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—JAK2—Crohn's disease	2.55e-05	6.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	2.55e-05	6.81e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—STAT3—Crohn's disease	2.53e-05	6.77e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	2.51e-05	6.7e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—STAT3—Crohn's disease	2.5e-05	6.68e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	2.44e-05	6.53e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.37e-05	6.35e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.34e-05	6.25e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	2.33e-05	6.24e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	2.33e-05	6.23e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	2.32e-05	6.22e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	2.29e-05	6.12e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.26e-05	6.04e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.22e-05	5.94e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—Crohn's disease	2.22e-05	5.93e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	2.21e-05	5.91e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	2.18e-05	5.82e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.17e-05	5.82e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	2.16e-05	5.79e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	2.13e-05	5.69e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—Crohn's disease	2.05e-05	5.49e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—Crohn's disease	2.05e-05	5.48e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	2.02e-05	5.41e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—Crohn's disease	1.99e-05	5.33e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—Crohn's disease	1.96e-05	5.25e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—Crohn's disease	1.95e-05	5.22e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.91e-05	5.11e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.88e-05	5.03e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—Crohn's disease	1.87e-05	5.02e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—Crohn's disease	1.87e-05	5.01e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	1.87e-05	5e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	1.84e-05	4.92e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—Crohn's disease	1.77e-05	4.73e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—Crohn's disease	1.74e-05	4.66e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	1.71e-05	4.57e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.71e-05	4.57e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.52e-05	4.06e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.51e-05	4.04e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—Crohn's disease	1.33e-05	3.57e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.31e-05	3.51e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—Crohn's disease	1.31e-05	3.5e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—Crohn's disease	1.31e-05	3.49e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.29e-05	3.44e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.19e-05	3.19e-05	CbGpPWpGaD
